Skip to main content

Advertisement

Log in

Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial–mesenchymal transition of cervical cancer cell lines

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Frizzled-7 (FZD7) has been demonstrated as a critical receptor of the Wnt signaling and involves in tumorigenesis and metastasis in many cancer types. However, limited information was found in cervical cancer. The aim of this study was to investigate the functional role of FZD7 in migration, invasion, and epithelial–mesenchymal transition (EMT) of cervical cancer cells. HeLa and SiHa cervical carcinoma cell lines with FZD7 expression were chosen in this study. A short hairpin RNA (shRNA) construct targeting FZD7 mRNA was transfected into HeLa and SiHa cells, and the stably transfected cell lines were obtained through G418 screening. Functional experiments were further performed to assess whether FZD7 down-regulation affects the migration, invasion, and EMT of HeLa and SiHa cells. Our results revealed that down-regulation of FZD7 expression significantly inhibited cell invasion and migration, as well as decreased the expression and activities of MMP2 and MMP9 in both cell types. Additionally, FZD7 silencing resulted in down-regulation of mesenchymal markers including Vimentin and Snail while increased the levels of epithelial marker E-cadherin. We further found that decreased FZD7 expression inhibited the phosphorylation levels of JNK and c-jun in both HeLa and SiHa cells, as determined by Western blot analysis and immunofluorescence. Overall, our results indicate that shRNA-mediated knockdown of FZD7 inhibits invasion, metastasis, and EMT of cervical cancer cells. FZD7 may provide a promising therapeutic target in cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99.

    Article  PubMed  Google Scholar 

  2. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22(12):2675–86. doi:10.1093/annonc/mdr015.

    Article  CAS  PubMed  Google Scholar 

  3. Partridge EE, Abu-Rustum N, Giuliano A, Massad S, McClure J, Dwyer M, et al. Cervical cancer screening. J Natl Compr Cancer Netw. 2014;12(3):333–41.

    Google Scholar 

  4. Kwak K, Yemelyanova A, Roden R. Prevention of cancer by prophylactic human papillomavirus vaccines. Curr Opin Immunol. 2011;23(2):244–51.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Manzo-Merino J, Contreras-Paredes A, Vazquez-Ulloa E, Rocha-Zavaleta L, Fuentes-Gonzalez AM, Lizano M. The role of signaling pathways in cervical cancer and molecular therapeutic targets. Arch Med Res. 2014;45(7):525–39. doi:10.1016/j.arcmed.2014.10.008.

    Article  CAS  PubMed  Google Scholar 

  6. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434(7035):843–50.

    Article  CAS  PubMed  Google Scholar 

  7. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochimica Biophysica Acta (BBA) Rev Cancer. 2003;1653(1):1–24.

    Article  CAS  Google Scholar 

  8. Perez-Plasencia C, Duenas-Gonzalez A, Alatorre-Tavera B. Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway. Int Arch Med. 2008;1(1):10.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Nambotin SB, Lefrancois L, Sainsily X, Berthillon P, Kim M, Wands JR, et al. Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma. J Hepatol. 2011;54(2):288–99.

    Article  CAS  PubMed  Google Scholar 

  10. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5(12):997–1014. doi:10.1038/nrd2154.

    Article  CAS  PubMed  Google Scholar 

  11. Dann CE, Hsieh J-C, Rattner A, Sharma D, Nathans J, Leahy DJ. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature. 2001;412(6842):86–90.

    Article  CAS  PubMed  Google Scholar 

  12. Kirikoshi H, Sekihara H, Katoh M. Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. Int J Oncol. 2001;19(1):111–5.

    CAS  PubMed  Google Scholar 

  13. Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan Y, et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene. 2011;30(43):4437–46.

    Article  CAS  PubMed  Google Scholar 

  14. Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, et al. Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma. J Hepatol. 2005;43(5):854–62.

    Article  CAS  PubMed  Google Scholar 

  15. Ueno K, Hiura M, Suehiro Y, Hazama S, Hirata H, Oka M, et al. Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia. 2008;10(7):697–705.

    PubMed Central  CAS  PubMed  Google Scholar 

  16. Asad M, Wong MK, Tan TZ, Choolani M, Low J, Mori S, et al. FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway. Cell Death Dis. 2014;5:e1346. doi:10.1038/cddis.2014.302.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. King TD, Zhang W, Suto MJ, Li Y. Frizzled7 as an emerging target for cancer therapy. Cell Signal. 2012;24(4):846–51. doi:10.1016/j.cellsig.2011.12.009.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Chung M-T, Lai H-C, Sytwu H-K, Yan M-D, Shih Y-L, Chang C-C, et al. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol. 2009;112(3):646–53. doi:10.1016/j.ygyno.2008.10.026.

    Article  CAS  PubMed  Google Scholar 

  19. Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, et al. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 2005;65(21):9762–70.

    Article  CAS  PubMed  Google Scholar 

  20. Qureshi R, Arora H, Rizvi M. EMT in cervical cancer: its role in tumour progression and response to therapy. Cancer Lett. 2015;356(2):321–31.

    Article  CAS  PubMed  Google Scholar 

  21. Menezes ME. The Wnt/β-catenin signaling pathway in epithelial mesenchymal transition. J Postdoc Res July. 2014;1:12.

    Google Scholar 

  22. Yook JI, Li X-Y, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem. 2005;280(12):11740–8.

    Article  CAS  PubMed  Google Scholar 

  23. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895–904.

    Article  CAS  PubMed  Google Scholar 

  24. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9–34. doi:10.1007/s10555-006-7886-9.

    Article  CAS  PubMed  Google Scholar 

  25. Moss LAS, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012;181(6):1895–9.

    Article  CAS  Google Scholar 

  26. Sheu B-C, Lien H-C, Ho H-N, Lin H-H, Chow S-N, Huang S-C, et al. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res. 2003;63(19):6537–42.

    CAS  PubMed  Google Scholar 

  27. Scheel C, Weinberg RA, editors. Cancer stem cells and epithelial–mesenchymal transition: concepts and molecular links. Seminars in cancer biology. Amsterdam: Elsevier; 2012.

  28. Xiang T, Li L, Yin X, Zhong L, Peng W, Qiu Z, et al. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. J Cell Mol Med. 2013;17(10):1236–46.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Veeck J, Dahl E. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochimica Biophysica Acta (BBA) Rev Cancer. 2012;1825(1):18–28.

    Article  CAS  Google Scholar 

  30. Vincan E, Barker N. The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clin Exp Metastasis. 2008;25(6):657–63.

    Article  CAS  PubMed  Google Scholar 

  31. Kennedy NJ, Davis RJ. Role of JNK in tumor development. Cell Cycle (Georgetown, Tex). 2002;2(3):199–201.

    Google Scholar 

  32. Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, et al. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009;101(8):1374–81.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a Grant from The First Affiliated Hospital of China Medical University (No. FSFH1214).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Boya Deng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, B., Zhang, S., Miao, Y. et al. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial–mesenchymal transition of cervical cancer cell lines. Med Oncol 32, 102 (2015). https://doi.org/10.1007/s12032-015-0552-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-015-0552-8

Keywords

Navigation